29.55
1.62%
+0.47
Dopo l'orario di chiusura:
29.55
Galapagos NV ADR Borsa (GLPG) Ultime notizie
Galapagos creates new subscription right plans
GlobeNewswire Inc.
Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.
GlobeNewswire Inc.
Are Medical Stocks Lagging Galapagos (GLPG) This Year? - Yahoo Singapore News
Yahoo Singapore News
Earnings call: Galapagos outlines strategic focus in Q1 2024 results - Investing.com
Investing.com
Biotech Stock Roundup: ALXN Up on Acquisition News, PFE-BNTX Get EUA for Vaccine & More - Yahoo News UK
Yahoo News UK
Galapagos’ aandeelhouders keuren alle door de Raad van Bestuur voorgestelde besluiten goed op de jaarlijkse Gewone en Buitengewone Algemene Aandeelhoudersvergaderingen 2024
GlobeNewswire Inc.
Down -9.97% in 4 Weeks, Here's Why You Should You Buy the Dip in Galapagos (GLPG)
Zacks Investment Research
Bristol Myers (BMY) Reports Positive Colorectal Cancer Study Data
Zacks Investment Research
Fate Therapeutics (FATE) Surges 86.4% YTD on Pipeline Progress
Zacks Investment Research
Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024
GlobeNewswire Inc.
Amylyx (AMLX) Withdraws ALS Drug, Cuts Workforce by 70%
Zacks Investment Research
After Plunging -7.94% in 4 Weeks, Here's Why the Trend Might Reverse for Galapagos (GLPG)
Zacks Investment Research
Bristol Myers (BMY) Wins EC Nod for Reblozyl Label Expansion
Zacks Investment Research
Disc Medicine (IRON) Down on Mixed Results From AURORA Study
Zacks Investment Research
Avalo Therapeutics (AVTX) Surges 270% in a Week: Here's Why
Zacks Investment Research
Galapagos Downgraded, Pharma Firm Faces Uphill Battle With Slow Pipeline Progress: Analyst
Benzinga
Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ Meetings
GlobeNewswire Inc.
Moderna (MRNA) Posts Pipeline Progress, Secures Blackstone Funding
Zacks Investment Research
Praxis (PRAX) Surges on Positive Epilepsy Study Results
Zacks Investment Research
Galapagos benoemt Andrew Dickinson tot Niet-Uitvoerend, Niet-Onafhankelijk Bestuurder van haar Raad van Bestuur
GlobeNewswire Inc.
Regeneron's (REGN) Lymphoma Candidate Rejected by the FDA
Zacks Investment Research
Novo Nordisk (NVO) Gets Positive CHMP Opinion for Insulin Icodec
Zacks Investment Research
Lifecore (LFCR) Down 30% on Ending Strategic Review With No Deal
Zacks Investment Research
Bayer's (BAYRY) Elinzanetant Meets Goals in Third Phase III Study
Zacks Investment Research
Down -14.35% in 4 Weeks, Here's Why Galapagos NV (GLPG) Looks Ripe for a Turnaround
Zacks Investment Research
Galapagos announces full year 2023 results and outlook for 2024
GlobeNewswire Inc.
Galapagos presenteert op de jaarlijkse EBMT-EHA meeting van 2024
GlobeNewswire Inc.
Galapagos completes transaction to transfer Jyseleca® business to Alfasigma
GlobeNewswire Inc.
Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.
GlobeNewswire Inc.
Galapagos gaat een strategische samenwerking aan met BridGene Biosciences om de ontdekking van kleine moleculegeneesmiddelen in oncologie uit te breiden
GlobeNewswire Inc.
Galapagos signs agreement to transfer Jyseleca® business to Alfasigma
GlobeNewswire Inc.
FDA Rejects Amgen's (AMGN) NDA Seeking Full Nod for Lumakras
Zacks Investment Research
Sarepta (SRPT) Seeks Label Expansion for DMD Gene Therapy
Zacks Investment Research
Jazz Pharmaceuticals' (JAZZ) PTSD Drug Misses Study Goals
Zacks Investment Research
Merck's (MRK) Chronic Cough Drug Gets Another CRL From FDA
Zacks Investment Research
FDA Accepts Merck's (MRK) BLA for 21-Valent Pneumococcal Jab
Zacks Investment Research
Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301
GlobeNewswire Inc.
Merck (MRK) Gets EU Nod for Expanded Use in Gastric Cancer
Zacks Investment Research
FDA Expands Merck's (MRK) Welireg Label in Renal Cell Carcinoma
Zacks Investment Research
Moderna (MRNA) Soars on Upbeat Data From Cancer Therapy Study
Zacks Investment Research
Buy These 4 Low-Beta Stocks to Counter Market Volatility
Zacks Investment Research
FDA Updates Labels of Esperion's (ESPR) Cholesterol-Lowering Drugs
Zacks Investment Research
Best Momentum Stocks to Buy for December 13th
Zacks Investment Research
New Strong Buy Stocks for December 13th
Zacks Investment Research
Galapagos presenteert nieuwe bemoedigende resultaten op ASH 2023 voor lopende CD19 CAR-T studies met GLPG5201 en GLPG5101
GlobeNewswire Inc.
Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at ASH 2023
GlobeNewswire Inc.
Morgan Stanley lists biotechs with negative enterprise value, 2022 catalysts (NASDAQ:GLPG) - Seeking Alpha
Seeking Alpha
Galapagos Begins Dosing With GLPG3970 in Psoriasis Study - Yahoo Singapore News
Yahoo Singapore News
The Daily Biotech Pulse: Gilead's Filgotinib Stumbles With FDA, J&J Laps Up Momenta In $6.5B Deal, 2 IPOs - Benzinga
Benzinga
The 5 Best-Performing Non-S&P Stocks of 2015 - Forbes
Forbes
Capitalizzazione:
|
Volume (24 ore):